LMCG Investments’s Dr. Reddy's Laboratories RDY Stock Holding History

LMCG Investments’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$8.13M	Buy	+636,140	New	+$7.9M	0.17%	229

Other funds holding RDY

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

OAM

Origin Asset Management London, United Kingdom $43.5M AUM 31.63% 1-Year Est. Return

LMCG Investments's RDY Position: Q3 2015 in Review

LMCG Investments opened a new position in Dr. Reddy's Laboratories (RDY) in Q3 2015: 636,140 shares worth $8.13M. The stake represents 0.17% of the portfolio and ranks #229 among its holdings.

206 funds tracked by Wall St. Rank hold RDY as of Q3 2015.

LMCG Investments held 636,140 shares of Dr. Reddy's Laboratories worth $8.13M as of Q3 2015.
Dr. Reddy's Laboratories was a new LMCG Investments position in Q3 2015.
Dr. Reddy's Laboratories made up 0.17% of LMCG Investments's portfolio in Q3 2015, its #229 holding.
206 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2015.

Based on LMCG Investments's 13F filing for Q3 2015, filed 4 Nov 2015.